Oramed Pharmaceuticals Inc.: Form 8-K, filed Feb 27, 2023
Filed with the SEC on Feb 27, 2023 and accepted by EDGAR at Feb 27, 2023, 17:05 ET.
Items reported
- Item 5.03 Amendment to articles or bylaws
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-23-014884. Last ingested by Listed: Nov 15, 2026, 04:14 ET. Listed shows no prices and gives no investment advice.